Adalimumab: 40 mg/0.8 mL injection, 2 x 0.8 mL cartridges; 40 mg/0.8 mL injection, 2 x 0.8 mL syringes; 40 mg/0.8 mL injection, 6 x 0.8 mL cartridges;40 mg/0.8 mL injection, 6 x 0.8 mL syringes, Humira®

Page last updated: 4 March 2016

• Public Summary Document (PSD) November 2015 PBAC Meeting - (PDF 535KB)
• Public Summary Document (PSD) November 2015 PBAC Meeting - (Word 64KB)